| Jump to: | Authorized Access | | | Attribution | | | Authorized Requests |
- Study Description
-
Important Links and Information
-
Request access via Authorized Access
- Instructions for requestors
- Data Use Certification (DUC) Agreement
- Talking Glossary of Genetic Terms
In this study, we performed single-cell transcriptomic profiling of human liver tissues collected from hepatocellular carcinoma and intrahepatic cholangiocarcinoma patients. A total of seven primary liver cancer patients enrolled in this study. Samples were collected from multiple regions, including tumor core, tumor border and adjacent non-tumor tissue. The 10x Genomics platform was used to generate single cell 5' libraries. The Illumina NovaSeq 6000 platform was employed for sequencing.
- Study Design:
- Case Set
- Study Type:
- Case Set
- Single Cell Analysis
- Total number of consented subjects: 7
- Subject Sample Telemetry Report (SSTR)
-
Request access via Authorized Access
- Authorized Access
- Publicly Available Data
- Link to other NCBI resources related to this study
- Study Inclusion/Exclusion Criteria
Only primary liver cancer patients were included in the study.
- Selected Publications
- Diseases/Traits Related to Study (MeSH terms)
-
- Primary Phenotype: Carcinoma, Hepatocellular
- Cholangiocarcinoma
- Liver Neoplasms
- Authorized Data Access Requests
- Study Attribution
-
-
Principal Investigator
- Xin Wei Wang, PhD. National Cancer Institute, Bethesda, MD, USA.
-
Principal Investigator